Sartorius | SRT3 - Operating Profit


Sartorius reported EUR179.8M in Operating Profit for its fiscal quarter ending in September of 2026.





Operating Profit Change Date
Akebia Therapeutics USD -5.45M 9.4M Dec/2025
Alaunos Therapeutics USD -1.01M 175K Mar/2026
Avita Medical AUD -10.41M 742K Dec/2025
Dianthus Therapeutics USD -46.53M 23.01M Mar/2026
Ionis Pharmaceuticals USD -102.29M 15.71M Jun/2026
IQVIA Holdings USD 608M 1.99B Sep/2026
Moderna USD -815M 573M Jun/2026
Organon & Co USD 323M 57M Jun/2026
Revvity USD 126.14M 43.36M Jun/2026
Sartorius EUR 179.8M 15.8M Sep/2026
Tectonic Therapeutic USD -27.3M 5.78M Mar/2026
Viatris USD 73.7M 93.9M Jun/2026
Xeris Pharmaceuticals USD 7.92M 8.86M Mar/2026